MedTrace Logo

Differents Laser Applications on Plantar Fasciitis

NCT06305507 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-01-02

No results posted yet for this study

Summary

The objective of this randomized controlled clinical trial (RCT) with a double-blind technique and longitudinal chronology, is to evaluate and compare the effectiveness of High intensity laser therapy (HILT) in static mode versus scanning mode in the reduction of pain associated with plantar fasciitis.

The main questions it seeks to answer are:

* What is the comparative effectiveness between low-level laser therapy in local spot mode and sweep mode in reducing pain in patients with plantar fasciitis?
* What are the optimal therapeutic parameters (session duration, frequency and power) for LLLT in both modes, maximizing pain reduction in patients with plantar fasciitis?

Participants in this study will perform the following tasks:

* Undergo HILT sessions or scanning mode.
* Comply with the instructions on the duration and frequency of the sessions.
* Record the pain levels experienced before and after each session.

The investigators will compare the group this differents laser to evaluate whether there are significant differences in pain reduction effects.

Conditions

  • Fasciitis, Plantar

Interventions

OTHER

Static therapy

The intervention involves the precise and focused application of HILT on specific areas related to plantar fasciitis. The static mode technique is characterized by directing the laser directly to the painful point, seeking optimal stimulation in the affected region.The Scanning Mode technique is characterized by applying the HILT through a continuous, sweeping movement of the handpiece over the target area

OTHER

Static Mode

The Scanning Mode technique is characterized by applying the HILT through a continuous, sweeping movement of the handpiece over the target area (the plantar fascia and adjacent tender regions). This application ensures a more uniform energy distribution across a larger tissue area, potentially addressing inflammation and pain in a broader region than the static mode. The total dose is distributed over the area treated with a continuous motion.

Sponsors & Collaborators

  • University of Seville

    lead OTHER

Principal Investigators

  • Aurora Castro Mendez, PhD · University of Seville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-06-30
Completion
2024-09-23

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06305507 on ClinicalTrials.gov